Ensuring Continued Access To Safe Medications During COVID-19 Pandemic

We are committed to the safety of our patients at all times. We continue to monitor federal and state actions related to COVID-19. On the federal level, we are reviewing guidance from HHS (including CMS), the CDC and the White House. For states, we are staying up-to-date on all shelter-in-place restrictions and reopening plans. We also continue to review the state directives from the Departments of Insurance and the Boards of Pharmacy.

Most importantly, all service teams across all lines of business as well as our Mail Order and Specialty Pharmacies are making sure you get the medication you need!

Important Updates on COVID-19

  • We continue to implement updates to Medicare Plans as recommended in the CMS CARES ACT.
  • Elixir's response to all CMS guidance will continue to be communicated in our Weekly HPMS Memo Action Tracker each Wednesday.

COVID-19 Vaccine Frequently Asked Questions

In December 2020, the U.S. Food and Drug Administration (FDA) issued emergency use authorizations (EUAs) allowing two COVID-19 vaccines to be distributed in the U.S. In late February 2021, the FDA issued an EUA for a third COVID-19 vaccine. Of the three options now available, one requires a single dose and two require two doses. Funding authorized by the CARES Act covers the cost of these COVID-19 vaccines. Members will not have to pay anything to get a COVID-19 vaccine.

Q: Will I be able to get the COVID-19 vaccine at my network pharmacies?
A: Yes. Once the vaccine is available to pharmacies in your network, claims for the administration of the vaccine for non-Medicare members will process through Elixir at $0 member copay. However, in the early phases, the vaccine will not be widely available to the general public.

Q: Why won’t it be widely available?
A: The Centers for Disease Control and Prevention (CDC) is making recommendations for who should get the vaccine first. You can learn more about these recommendations here.

Q: How can I learn more about getting a vaccine in my state?
A: We have prepared a state-by-state guide that may help. Click here to view the guide, and select your state to learn more.

Q: Will COVID-19 vaccines be covered by Medicare?
Yes. If you are enrolled in a Medicare Advantage plan during calendar year 2020 and 2021, payment for the COVID-19 vaccine and its administration will be made through the original fee-for-service Medicare program. That means that both doses will be available to you at no copay/cost share or deductible. Please present your red, white, and blue Medicare card at the pharmacy at the time of vaccination.

Q: If I am not a Medicare member, will the COVID-19 vaccine be covered by my plan, and what will it cost?
A: Elixir members who are not enrolled in a Medicare Advantage plan can receive both doses of the vaccine at no copay/cost share or deductible. The federal government has purchased the initial supply of vaccines, so the vaccine itself will be paid for through funding authorized by the CARES Act. Some pharmacies may charge an administration fee, but that should be paid for by your plan.

Q: Will the price be different if I have to go to an out-of-network (OON) pharmacy?
A: No. Members will receive both doses of the vaccine at no copay/cost share or deductible.

Q: Will the vaccine only be available at certain pharmacies?
A: Yes. To receive free supplies of COVID-19 vaccines, pharmacies, retail clinics, providers, and others must sign an agreement with the U.S. government.

Q: How will COVID-19 vaccines work?
A: COVID-19 vaccines will work like other vaccines, which expose recipients to antigens. These antigens help those who are vaccinated to develop an immune response that will be able to block or kill the virus if a person becomes infected.

Q. Will the COVID-19 vaccine be like the flu vaccine and require annual dosing?
A: Although some vaccines can provide long-lasting immunity, we do not have enough information to know about these yet. Currently, no additional doses beyond the primary single or two-dose series are recommended at this time.

Q: Most vaccines take years to develop. How have we been able to speed up development for a COVID-19 vaccine and has that affected its safety?
A: It’s correct that vaccine development typically takes years. However, in this case, developers were able to speed up the process, in part because of efforts that had been underway on previously known coronaviruses (SARS-CoV-1 and MERS CoV). In addition, the U.S. government aided the process by allowing manufacturing to start while the clinical trials were ongoing. Data collected from thousands of participants in clinical trials help the FDA determine the safety of the vaccine. Both currently available options have been shown to be safe and effective.

Q: What is emergency use authorization?
A: An EUA is a way to facilitate the availability and use of medical treatments, including vaccines, during public health emergencies. Under an EUA, the FDA may allow unapproved medical products, or unapproved uses of approved medical products, in an emergency to diagnose, treat or prevent serious or life-threatening diseases or conditions.

Q: What are some of the clinical details about these vaccines?
A: Two of the currently offered vaccines are messenger RNA vaccines, or mRNA vaccines. These use a new approach to protecting against infectious diseases and are the first of their kind to be licensed in the United States. The third vaccine is manufactured using adenovirus type 26 (Ad26) to deliver a piece of the DNA, or genetic material, that is used to make the distinctive “spike” protein of the SARS-CoV-2 virus. 

The two-dose vaccines are not interchangeable; both required doses have to be the same vaccine.

The CDC advises that vaccine providers observe patients with a history of allergic reactions (due to any cause) for 30 minutes after vaccination. All other persons should be observed for 15 minutes after vaccination to monitor for the occurrence of immediate adverse reactions. The CDC also states that appropriate medical treatment must be immediately available to treat a patient who experiences a severe allergic reaction to the vaccine.

Q: Does Elixir Mail Order Pharmacy have the vaccine?
A: No. As a mail order pharmacy, Elixir Pharmacy is unable to administer the vaccine directly to members.

Q: Are COVID-19 vaccines available at Rite Aid locations?
A: Yes. For updated information on vaccine eligibility in your area and for scheduling appointments at Rite Aid, view the Eligibility Guide. Vaccine doses are extremely limited, and availability is updated daily. Store and pharmacy associates are not able to schedule appointments.


How to Ensure You Continue To Receive Your Medication/s Safely:
  • Refill online. Use your preferred pharmacy's website or phone number to refill prescriptions for retail and/or home delivery.
  • Use mail order. For current mail order and specialty patients:
    • To request refills of your Elixir Mail medications, log in to the portal at elixirsolutions.com.
    • For refills of your Elixir Specialty Pharmacy medications, please call a Care Coordinator at 877-437-9012 to order a refill or to set up online ordering. Our Call Center regular business hours are Monday through Friday 8:00 am-4:30 pm EST. 
  • Stay in your car. If you need to go to the retail pharmacy, use the drive through where available for convenience and social distancing.
  • Ask about home delivery. Your pharmacy may provide delivery to your home; there may be additional charges. Ask your pharmacy.
  • Running low? If you are concerned about running low on medication, ask your pharmacist about filling the medications you need.
  • Ask about 90-day prescription fills. If your plan allows you to fill a 90 day supply, ask your pharmacy to do so, or request your doctor send a mail order prescription for 90-days to be filled.
  • Approvals are still required. Some medications require prior authorization from your doctor. At this time, all existing prior authorization rules are still in place. If your plan sponsor opts to change these rules, we will implement them on a plan-by-plan basis.
  • Don’t worry. We are monitoring any drug shortages.
    • Both our home delivery and specialty pharmacy have dramatically increased normal medication supply levels to ensure no interruption in therapy.

Members, Clients, Pharmacies And Providers Can Engage Customer Care Via:

  • Phone
    • Call our dedicated toll-free number, 800-361-4542.
    • For Elixir Pharmacy, call 866-909-5170 (TTY: 711) 24 hours daily. 
    • Please note: Call volume may be high during certain times of the day.
  • App
    • Elixir's mobile app is available in your device's app store.
    • Members who currently use Elixir Specialty Pharmacy can manage specialty prescriptions and chat with Care Navigators through the Citus Health app, which is available in your device's app store.
  • Member Portal
    • elixirsolutions.com
      • Register/log in to the member portal
        • Use your member ID to gain access
      • Review your coverage
      • Find in-network pharmacies
      • Display/print your ID card
      • Get drug pricing
      • View your claims history 

What We Are Doing To Help You Stay Safe

  • Expanded on our already extraordinary measures to keep our facilities clean
  • Provided additional training to employees on cleaning workstations and recognizing symptoms of the virus
  • Implemented a companywide work-from-home policy for non-service positions to help contain the spread of the virus
  • Increased our normal medication supply levels

We will continue to monitor this situation and implement any necessary measures to keep our employees safe and healthy so that they, in turn, can provide the best quality services to you.

Stay informed on Coronavirus (COVID-19)

While we’re concerned about the recent developments surrounding COVID-19 (coronavirus), we’re also confident that staying informed and hygienic are the best ways to protect yourself, your family and your community. Because the situation changes daily, we encourage you to routinely check this site for important health and safety updates.

Go to the CDC’s website for more ways to protect yourself and your loved ones. 


Please note: By clicking the link above you are leaving the Elixir website. 

What you need to know about Coronavirus


What is coronavirus disease 2019 (COVID-19)?

Coronavirus is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.

How does COVID-19 spread?

The virus seems to be spreading from person to person. At this time, it’s unclear how easily or sustainably the virus is spreading between people. Learn more at https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html.   

Please note: By clicking the link above you are leaving the Elixir website.

What are the symptoms of COVID-19?

Patients have experienced mild to severe respiratory illness with symptoms of fever, cough and/or shortness of breath.

fever          cough          shortness of breath

How to help prevent the spread of germs


Follow the CDC's helpful guide to protect yourself and your loved ones:


Avoid close contact with people who are sick.


Cover your cough or sneeze with a tissue, then throw the tissue in the trash.


Avoid touching your eyes, nose, and mouth.


Clean and disinfect frequently touched objects and surfaces.


Stay home when you are sick, except to get medical care.


Wash your hands often with soap and water for at least 20 seconds.


Please check back soon. We are actively gathering important information and answers to your questions regarding COVID-19.